BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 35833114)

  • 1. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
    Chen M; Wang X; Wang W; Gui X; Li Z
    Front Immunol; 2022; 13():829057. PubMed ID: 35833114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
    Zhang H; Cao C; Xiong H
    Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
    Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
    Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
    Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
    Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
    Front Genet; 2022; 13():860268. PubMed ID: 35464867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
    Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
    Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
    Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
    Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma.
    Yi Y; Liu X; Gao H; Qin S; Xu J; Ma F; Guan M
    Biochem Genet; 2023 Dec; 61(6):2401-2424. PubMed ID: 37100923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.
    Wan R; Liao H; Liu J; Zhou L; Yin Y; Mu T; Wei J
    Biomed Res Int; 2022; 2022():4404406. PubMed ID: 35480140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
    Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
    J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma.
    Wang H; Wang Y; Luo W; Zhang X; Cao R; Yang Z; Duan J; Wang K
    BMC Pulm Med; 2022 Dec; 22(1):463. PubMed ID: 36471379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes.
    Chen F; Ma J; Hu S; Wu C; Chen S; Lin J
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
    Li W; Ou D; Zhang J; Ye M
    Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
    Cao X; Ji Y; Li J; Liu Z; Chen C
    Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma.
    He X; Su Y; Liu P; Chen C; Chen C; Guan H; Lv X; Guo W
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7379-7392. PubMed ID: 36939925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.